Skip to main content
logo
AstraZeneca Pharma India Limited (NSE:ASTRAZEN)
India flag India · Delayed Price · Currency is INR
9,036.00
-35.50 (-0.39%)
Sep 12, 2025, 12:29 PM IST

Revenue by Product

Fiscal year is April - March.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202005 - 2019
Period Ending
Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2005 - 2019
Tablets
8.98B
Log In
Log In
Log In
Log In
Upgrade
Tablets Growth
3.16%
Log In
Log In
Log In
Log In
Upgrade
Injectables
6.83B
Log In
Log In
Log In
Log In
Upgrade
Injectables Growth
115.62%
Log In
Log In
Log In
Log In
Upgrade
Clinical Trials
1.05B
Log In
Log In
Log In
Log In
Upgrade
Clinical Trials Growth
16.65%
Log In
Log In
Log In
Log In
Upgrade
Inhalation
272.50M
Log In
Log In
Log In
Log In
Upgrade
Inhalation Growth
50.80%
Log In
Log In
Log In
Log In
Upgrade
Other
30.00M
Log In
Log In
Log In
Log In
Upgrade
Grant of Exclusive Distribution Rights
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is April - March.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202005 - 2019
Period Ending
Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2005 - 2019
India
16.07B
Log In
Log In
Log In
Log In
Upgrade
India Growth
33.67%
Log In
Log In
Log In
Log In
Upgrade
International
1.10B
Log In
Log In
Log In
Log In
Upgrade
International Growth
17.19%
Log In
Log In
Log In
Log In
Upgrade